Heart pump and ultrasound heart function study
Part of Heart & circulation clinical trials.
This study uses ultrasound (echocardiography) to see how the Impella 5.5 heart pump affects your heart's pumping ability, especially the right side. It might help doctors better understand and care for people who need this pump.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You need to have an Impella 5.5 heart pump placed.
- You can make your own decisions about joining the study.
- You do not have any problems with your throat or esophagus that make an ultrasound probe risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a noninvasive ultrasound-based method can help diagnose what’s going on in people with a HeartMate 3 blood pump. It may help detect important pump-related changes while keeping the process safer for certain high-risk situations.
This study tests whether using a temporary heart pump called Impella 5.5 can help strengthen a very weak and enlarged heart (dilated cardiomyopathy) in people who are waiting for a heart transplant. If you qualify, the pump is placed to support your heart temporarily, and the research team will check how your heart responds.
This study looks at used Impella heart pumps to see what deposits build up on them during treatment. If you've had an Impella pump for a certain length of time, this study helps doctors learn more about the device.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This study is for people in the intensive care unit who are using a heart pump called Impella. It will collect information about how well the heart pumps blood during treatment to help doctors learn more.
This study looks at using a temporary heart pump called Impella ECP during planned high-risk heart stent procedures (PCI). It may help doctors support the heart more safely while placing the stents.
Hear when a new End-stage Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.